Sarda Proteins Ltd (BOM:519242)
India flag India · Delayed Price · Currency is INR
97.78
0.00 (0.00%)
At close: Aug 3, 2026

Sarda Proteins Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
181.97161.58241.9112.9657.95107.6
Revenue Growth
-48.23%-33.20%1766.88%-77.64%-46.14%-5.28%
Gross Profit
43.016.82.80.890.774.73
Operating Income
-24.842.90.2-1.46-1.472.7
Net Income
27.916.380.050.19-0.333.07
Earnings Per Share
7.893.700.030.11-0.191.78
EPS Growth
-12421.57%-73.14%---

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
75.175.10.341.191.843.26
Total Debt
1.551.55----
Net Cash (Debt)
73.5573.550.341.191.843.26
Net Cash Growth
21659.47%21659.47%-71.53%-35.62%-43.41%143.29%
Net Cash Per Share
20.8042.660.200.691.071.89

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
--763.89-1.11-2.31-3.011.04
Capital Expenditures
------
Free Cash Flow
--763.89-1.11-2.31-3.011.04
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
23.63%4.21%1.16%6.84%1.34%4.40%
Operating Margin
-13.65%1.79%0.08%-11.30%-2.54%2.51%
Pretax Margin
18.38%3.95%0.08%1.46%0.22%3.28%
Profit Margin
15.34%3.95%0.02%1.50%-0.57%2.86%
FCF Margin
--472.75%-0.46%-17.82%-5.20%0.97%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
12.39118.874221.69478.54-20.94
P/FCF Ratio
-----61.76
PS Ratio
4.824.690.897.161.720.60